SACRAMENTO, Calif. -- The University of California, Davis, and BGI, the world's largest genomic institute, based in China, have signed a historic agreement that will change the landscape of genomic sciences in California and the Western states, and foster critical breakthroughs in the areas of food security and human, animal and environmental health. The new partnership will establish a state-of-the-art BGI sequencing facility for immediate use on the UC Davis Health System campus in Sacramento, and initiate planning for a permanent BGI@UC Davis Joint Genome Center.
The new sequencing facility will be used to support research initiatives and collaborations and leverage existing strengths across the Davis and Sacramento campuses in human and animal health and medicine, food safety and security, biology, and the environment. When complete, the permanent center will occupy about 10,000 square feet on the health system campus in Sacramento, initially adding approximately 20 high-skilled jobs. Ultimately, the center will increase UC Davis' DNA sequencing capability approximately tenfold and generate an estimated 200 new jobs in the Sacramento region.
A signing ceremony for the BGI@UC Davis Partnership was held Monday night at the UC Davis MIND Institute in Sacramento. Participating in the ceremony were Harris Lewin, vice chancellor for research at UC Davis; Jun Wang, executive director of BGI, headquartered in Shenzen, China; and Greg Wang, chief executive officer of BGI Americas, headquartered in Cambridge, Mass. Also taking part were Qin Xu, the mayor of Shenzhen, and Kevin Johnson, mayor of Sacramento.
"UC Davis brings to this partnership phenomenal faculty conducting cutting-edge research on food, health, energy and the environment, while BGI is a world leader in genome sequencing and analysis," said UC Davis Chancellor Linda P.B. Katehi. "Together, as partners, UC Davis and BGI will be able to take on the biggest challenges in biol
|Contact: Andy Fell|
University of California - Davis